The latest brain, head and neck cancer news
Machine-learning models may improve postoperative risk stratification and help guide decisions about adjuvant therapy in…
In a Phase 3 randomised trial, Mass General Brigham researchers found that stereotactic radiation targeting…
Oral cancers with a high risk of recurrence can be identified at an early stage…
A team led by investigators at Mass General Brigham and Dana-Farber Cancer Institute, USA, has…
Recurrent or metastatic nasopharyngeal carcinoma (RM-NPC) is a distinct head and neck malignancy strongly linked…
Head and neck cancer trials are frequently derailed before they can deliver answers. A new…
Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets…
Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection…
A novel tumour suppressor, BATF2, can be silenced by factors in the tumour microenvironment, leading to…
An artificial saliva in the form of a mouthwash, produced with the CANECPI-5 protein extracted…